Nuvectis Pharma Inc.

NVCT | NASDAQ

Price Alert Chart Builder DCF Calculator

$22.82

+$0.84 (+3.82%)

Sep 22, 2026, 1:36 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Quarter Period Ending	Q2 2026 Jun 29, 2026	Q1 2026 Mar 30, 2026	Q4 2025 Dec 30, 2025	Q3 2025 Sep 29, 2025	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023	Q2 2023 Jun 29, 2023	Q1 2023 Mar 30, 2023	Q4 2022 Dec 30, 2022	Q3 2022 Sep 29, 2022	Q2 2022 Jun 29, 2022	Q1 2022 Mar 30, 2022	Q4 2021 Dec 30, 2021	Q3 2021 Sep 29, 2021	Q2 2021 Jun 29, 2021	Q1 2021 Mar 30, 2021
Net Income	-13.07M	-6.05M	-7.31M	-7.46M	-6.33M	-5.33M	-6.25M	-4.15M	-4.43M	-4.17M	-6.62M	-5.88M	-5.71M	-4.05M	-6.7M	-5.88M	-3.57M	-2.94M	-2.26M	-4.67M	-5.94M	-23K
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	3.56M	1.85M	1.48M	1.46M	1.73M	1.37M	1.14M	1.16M	1.26M	1.3M	1.22M	1.13M	950K	1.4M	482K	559K	510K	156K	185K	136K	1.57M	n/a
Other Working Capital	-441K	-732K	2.03M	49K	-749K	-704K	2.41M	175K	59K	-471K	1.55M	-185K	968K	-1.32M	2.7M	894K	516K	-289K	1.01M	n/a	356K	23K
Other Non-Cash Items	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	23K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-1.53M	-2.31M	1.86M	1.51M	1.24M	-210K	2.64M	590K	146K	-1.48M	1.55M	1.5M	675K	-2.13M	2.7M	894K	516K	-289K	1.01M	106K	356K	23K
Operating Cash Flow	-11.04M	-6.51M	-3.97M	-4.49M	-3.37M	-4.17M	-2.47M	-2.4M	-3.02M	-4.36M	-3.85M	-3.24M	-4.08M	-4.78M	-3.52M	-4.42M	-2.54M	-3.08M	-1.07M	-4.43M	-4.01M	n/a
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-4K	n/a	-82K	-407K	-318K	-1.29M	-124K	-50K	-55K	-153K	16K	-423K	9.95M	252K	-131K	-1.39M	-578K	-1.97M	n/a	n/a	11.23M	n/a
Financial Cash Flow	1.57M	7K	166K	13.14M	296K	15.51M	3.83M	1.46M	1.67M	4.7M	917K	703K	13.22M	252K	-131K	14.49M	-578K	14.03M	n/a	4.02M	11.23M	n/a
Net Cash Flow	-9.47M	-6.5M	-3.81M	8.65M	-3.07M	11.33M	1.36M	-947K	-1.35M	338K	-2.93M	-2.54M	9.13M	-4.53M	-3.65M	10.07M	-3.12M	10.95M	-1.07M	-405K	7.21M	n/a
Free Cash Flow	-11.04M	-6.51M	-3.97M	-4.49M	-3.37M	-4.17M	-2.47M	-2.4M	-3.02M	-4.36M	-3.85M	-3.24M	-4.08M	-4.78M	-3.52M	-4.42M	-2.54M	-3.08M	-1.07M	-4.43M	-4.01M	n/a
Adj. Free Cash Flow	-14.6M	-8.36M	-5.45M	-5.95M	-5.1M	-5.54M	-3.61M	-3.56M	-4.28M	-5.65M	-5.07M	-4.38M	-5.03M	-6.18M	-4M	-4.98M	-3.05M	-3.23M	-1.25M	-4.56M	-5.58M	n/a
Maintenance CapEx	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Growth CapEx	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Owner Earnings	-11.04M	-6.51M	-3.97M	-4.49M	-3.37M	-4.17M	-2.47M	-2.4M	-3.02M	-4.36M	-3.85M	-3.24M	-4.08M	-4.78M	-3.52M	-4.42M	-2.54M	-3.08M	-1.07M	-4.43M	-4.01M	n/a